Literature DB >> 17998049

Characterization of ankyrin repeat-containing proteins as substrates of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible transcription factor.

Sarah Linke1, Rachel J Hampton-Smith, Daniel J Peet.   

Abstract

The hypoxia-inducible transcription factors (HIFs) are essential mediators of the genomic response to oxygen deficiency (hypoxia) in multicellular organisms. The HIFs are regulated by four oxygen-sensitive hydroxylases-three prolyl hydroxylases and one asparaginyl hydroxylase. These hydroxylases are all members of the 2-oxoglutarate (2OG)-dependent dioxygenase superfamily and convey changes in cellular oxygen concentration to the HIF-alpha (alpha) subunit, leading to potent accumulation and activity in hypoxia versus degradation and repression in normoxia. HIF-alpha asparaginyl hydroxylation is catalyzed by factor-inhibiting HIF-1 (FIH-1) and directly regulates the transcription activity of the HIF-alpha proteins. Recent work has demonstrated that, in addition to hydroxylating HIF-alpha, FIH-1 can also hydroxylate the ankyrin domains of a wide range of proteins. This paper presents in vitro and cell-based techniques for the preliminary characterization of ankyrin domain-containing proteins as FIH-1 substrates and interacting proteins. Strategies are presented for the expression and purification of FIH-1 from mammalian or bacterial cells. Similar to the HIF-alpha proteins, the ankyrin-containing substrates are examined as purified proteins expressed in bacteria and overexpressed in mammalian cells or in the form of synthetic peptides. Specific conditions for the efficient expression of ankyrin-containing proteins compared with the HIF-alpha substrates in Escherichia coli are detailed. Hydroxylation is rapidly inferred, utilizing the described in vitro CO(2) capture assay. Finally, substrate and non-substrate interactions are examined using in vitro affinity pull-down assays and mammalian cell-based co-immunoprecipitation assays. Together, these methods are rapid and well suited to the preliminary characterization of potential substrates of the therapeutically relevant oxygen-sensing enzyme FIH-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998049     DOI: 10.1016/S0076-6879(07)35004-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  14 in total

1.  Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates.

Authors:  Sarah E Wilkins; Sarah Karttunen; Rachel J Hampton-Smith; Iain Murchland; Anne Chapman-Smith; Daniel J Peet
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  Consequences of IkappaB alpha hydroxylation by the factor inhibiting HIF (FIH).

Authors:  Ingrid L Devries; Rachel J Hampton-Smith; Melinda M Mulvihill; Vera Alverdi; Daniel J Peet; Elizabeth A Komives
Journal:  FEBS Lett       Date:  2010-11-05       Impact factor: 4.124

3.  Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.

Authors:  Da-Yuan Chen; Jacqueline-Alba Fabrizio; Sarah E Wilkins; Keyur A Dave; Jeffrey J Gorman; Jonathan M Gleadle; Stephen B Fleming; Daniel J Peet; Andrew A Mercer
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  The muscle ankyrin repeat proteins are hypoxia-sensitive: in vivo mRNA expression in the hypoxia-tolerant blind subterranean mole rat, Spalax ehrenbergi.

Authors:  Mark Band; Alma Joel; Aaron Avivi
Journal:  J Mol Evol       Date:  2009-12-05       Impact factor: 2.395

5.  Modulation of CP2 family transcriptional activity by CRTR-1 and sumoylation.

Authors:  Sarah To; Stephen J Rodda; Peter D Rathjen; Rebecca A Keough
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

6.  Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.

Authors:  Paul W Furlow; Melanie J Percy; Scott Sutherland; Charlene Bierl; Mary Frances McMullin; Stephen R Master; Terence R J Lappin; Frank S Lee
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

7.  Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis.

Authors:  M N Khan; T Bhattacharyya; P Andrikopoulos; M A Esteban; R Barod; T Connor; M Ashcroft; P H Maxwell; S Kiriakidis
Journal:  Br J Cancer       Date:  2011-03-08       Impact factor: 7.640

8.  Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls.

Authors:  A Hayashi; K Le Gal; K Södersten; D Vizlin-Hodzic; H Ågren; K Funa
Journal:  Mol Psychiatry       Date:  2014-10-14       Impact factor: 15.992

9.  FIH Regulates Cellular Metabolism through Hydroxylation of the Deubiquitinase OTUB1.

Authors:  Carsten C Scholz; Javier Rodriguez; Christina Pickel; Stephen Burr; Jacqueline-Alba Fabrizio; Karen A Nolan; Patrick Spielmann; Miguel A S Cavadas; Bianca Crifo; Doug N Halligan; James A Nathan; Daniel J Peet; Roland H Wenger; Alex Von Kriegsheim; Eoin P Cummins; Cormac T Taylor
Journal:  PLoS Biol       Date:  2016-01-11       Impact factor: 8.029

10.  Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

Authors:  Matthew E Cockman; James D Webb; Holger B Kramer; Benedikt M Kessler; Peter J Ratcliffe
Journal:  Mol Cell Proteomics       Date:  2008-10-20       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.